A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update
Year: 2013
Type: article
Study design: Clinical Trial
Source: European Journal of Cancer
Institutions: Azienda Ospedaliera San Camillo-Forlanini, Carlo Forlanini Hospital, Cancer Research UK, University of Manchester, The Christie Hospital, The Christie NHS Foundation Trust, Singleton Hospital, Fundación Arturo López Pérez, Národný Onkologický Ústav, Pontifícia Universidade Católica do Rio Grande do Sul, Instituto Médico Río Cuarto, Centro Médico Sanitas Córdoba, Chelyabinsk Regional Clinical Oncology Center, Seoul National University, Wojskowy Instytut Medyczny, GlaxoSmithKline (United States), Ludwig Cancer Research, Austin Health
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: GlaxoSmithKline, Victorian Cancer Agency
OpenAlex ID: W2047871200
